MDBH - Latest News
MDB Capital Holdings, LLC Class A common (MDBH), operates in Financial Services / Financial - Capital Markets, trades on NASDAQ.
Market capitalization stands near $37.9M. Beta to the broader market is 1.27.
The article list below shows the most recent MDBH headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent MDBH Headlines
PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana
globenewswire.com - May 19, 2026
� New case study highlights how PatentVest helped Docana navigate a complex AI patent landscape through freedom-to-operate analysis, competitive intel
New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market
globenewswire.com - May 8, 2026
� Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech pla
Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
globenewswire.com - Apr 29, 2026
Dallas, TX, April 29, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse: “The Last 20%: Retatrutide, the Glucagon Paradox
MDB Capital Holdings, LLC (MDBH) Q4 2025 Earnings Call Transcript
seekingalpha.com - Mar 31, 2026
MDB Capital Holdings, LLC (MDBH) Q4 2025 Earnings Call Transcript
PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment
globenewswire.com - Mar 31, 2026
Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs,
How News Affects MDBH Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MDBH's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked MDBH news questions
- What is the latest MDBH news headline?
- The most recent MDBH headline (May 19, 2026) is "PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the MDBH news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What MDBH news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual MDBH options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.